Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 159,873
  • Shares Outstanding, K 90,324
  • Annual Sales, $ 59,350 K
  • Annual Income, $ -65,280 K
  • EBIT $ -60 M
  • EBITDA $ -53 M
  • 60-Month Beta 2.47
  • Price/Sales 2.57
  • Price/Cash Flow N/A
  • Price/Book 3.96

Options Overview Details

View History
  • Implied Volatility 372.32% (+233.88%)
  • Historical Volatility 89.93%
  • IV Percentile 97%
  • IV Rank 69.23%
  • IV High 527.58% on 09/05/25
  • IV Low 23.08% on 09/09/25
  • Expected Move (DTE 14) 0.6375 (35.61%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 2,718
  • Open Int (30-Day) 2,779
  • Expected Range 1.1525 to 2.4275

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.03
  • Low Estimate -0.02
  • Prior Year -0.13
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5200 +17.76%
on 11/24/25
2.1600 -17.13%
on 11/06/25
-0.3600 (-16.74%)
since 11/05/25
3-Month
1.5200 +17.76%
on 11/24/25
2.9299 -38.91%
on 10/10/25
-0.6300 (-26.03%)
since 09/05/25
52-Week
1.5200 +17.76%
on 11/24/25
6.0800 -70.56%
on 12/11/24
-2.8400 (-61.34%)
since 12/05/24

Most Recent Stories

More News
Codexis Announces Signing of Lease for GMP Manufacturing Facility

REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.8150 (+2.54%)
Codexis: Q3 Earnings Snapshot

Codexis: Q3 Earnings Snapshot

CDXS : 1.8150 (+2.54%)
Codexis Reports Third Quarter 2025 Financial Results

Announces signing of $37.8m Supply Assurance Agreement with Merck Organizational changes streamline company and reduce operational expenses Cash runway extended through 2027 REDWOOD CITY,...

CDXS : 1.8150 (+2.54%)
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing

REDWOOD CITY, Calif. , Oct. 29, 2025 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko...

CDXS : 1.8150 (+2.54%)
Codexis to Report Third Quarter 2025 Financial Results on November 6

REDWOOD CITY, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.8150 (+2.54%)
Codexis to Participate in Cantor Global Healthcare Conference

REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics,...

CDXS : 1.8150 (+2.54%)
Codexis: Q2 Earnings Snapshot

Codexis: Q2 Earnings Snapshot

CDXS : 1.8150 (+2.54%)
Codexis Reports Second Quarter 2025 Financial Results

Announces revenue of $15.3M vs $14.1M analyst consensus estimate Six presentations featured ECO Synthesis® platform at 2025 TIDES USA annual meeting, including three from leading CDMO collaborators...

CDXS : 1.8150 (+2.54%)
Codexis to Report Second Quarter 2025 Financial Results on August 13

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.8150 (+2.54%)
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA

CDXS : 1.8150 (+2.54%)

Business Summary

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and...

See More

Key Turning Points

3rd Resistance Point 1.9183
2nd Resistance Point 1.8467
1st Resistance Point 1.8083
Last Price 1.8150
1st Support Level 1.6983
2nd Support Level 1.6267
3rd Support Level 1.5883

See More

52-Week High 6.0800
Fibonacci 61.8% 4.3381
Fibonacci 50% 3.8000
Fibonacci 38.2% 3.2619
Last Price 1.8150
52-Week Low 1.5200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar